|
Cost-Effectiveness of Lung Volume Reduction Surgery Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Cost-Effectiveness of Lung Volume Reduction Surgery conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Cost-Effectiveness of Lung Volume Reduction Surgery Clinical research trials and Cost-Effectiveness of Lung Volume Reduction Surgery healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Cost-Effectiveness of Lung Volume Reduction Surgery. Cost-Effectiveness of Lung Volume Reduction Surgery Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Cost-Effectiveness of Lung Volume Reduction Surgery clinical trial. Participants typically obtain the most effective healthcare available for their Cost-Effectiveness of Lung Volume Reduction Surgery condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Cost-Effectiveness of Lung Volume Reduction Surgery  Cost-Effectiveness of Lung Volume Reduction Surgery
Cost-Effectiveness of Lung Volume Reduction Surgery
For Condition: Emphysema,Chronic Obstructive Pulmonary Disease
Status: Completed
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service
Synopsis: Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS. Evaluate cost-effectiveness of LVRS compared to current therapy for COPD. This is a case control study in which veterans undergoing LVRS at VA Puget Sound Health Care System (VAPSHCS) are compared to patients with a similar severity of disease at Boise VAMC who are not undergoing LVRS. Changes in health related quality of life are being evaluated using three instruments: the SF-36, the St. George?s Respiratory Questionnaire, and the Quality of Well-Being Scale, the latter to calculate utility associated with different health states. Costs will be determined using utilization data on outpatient visits, medications, oxygen use, inpatient days, radiology tests, laboratory tests, and emergency room visits are being collected for the twelve months before and after surgery. Costs will be calculated according to VA and community standards.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Male
Protocol Entry Criteria: Severe COPD as defined by FEV1 of 20-30% predicted; marked hyperinflation with a residual volume of >165% predicted; 6-min walk greater than 600 ft; abstinence from cigarette smoking for 3-mths; absence of co-morbid illnesses that would significantly increase surgical risk, such as severe coronary artery disease
Total Enrollment: 92
Location and Contact Information:
VA Medical & Regional Office Center
White River Junction, Vermont, 05009-0001
United States
Seattle Medical Center
Seattle, Washington, 98108
United States
Additional Information:
Study ID Numbers: IIR 96-024;
Study Start Date: October 1997
Record last reviewed: October 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00013156
Other Emphysema Studies:
1. OPUS Study: Effect of Roflumilast on exacerbation rate in patients with chronic obstructive pulmonary disease
2. Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects with COPD
3. Nocturnal Oxygen Therapy
4. Chronic Obstructive Pulmonary Disease Gene Localization
5. Lay-Led Smoking Cessation Approach for Southeast Asian Men
Related Studies:
Other Emphysema Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
Cost-Effectiveness of Lung Volume Reduction Surgery
|
|
|
|
|
|
|
|
